SCHEMBL34405

SCHEMBL34405

O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)ccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 5/20 1.00
TNKS2 Q9H2K2 5/20 1.00
PARP1 P09874 4/20 1.00
ALOX5 P09917 3/20 1.00
POLH Q9Y253 3/20 1.00
CYP3A4 P08684 7/20 0.77
HPGD P15428 7/20 0.77
ALDH1A1 P00352 5/20 0.77
SMN1; SMN2 Q16637 5/20 0.77
KDM4E B2RXH2 4/20 0.77
HSD17B10 Q99714 4/20 0.77
IP6K2 Q9UHH9 4/20 0.77
CYP19A1 P11511 3/20 0.77
MAOA P21397 3/20 0.77
MAOB P27338 3/20 0.77
MAPK1 P28482 3/20 0.77
QPCT Q16769 3/20 0.77
MPO P05164 1/20 0.77
PTPRS Q13332 1/20 0.76
MEN1 O00255 5/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29678122 1.00 TNKS (1.00) TNKSTNKS2PARP1ALOX5POLH
SCHEMBL30591365 0.88 ALOX5 (0.78) TNKSTNKS2PARP1ALOX5POLH
SCHEMBL29664594 0.88 ALOX5 (0.78) TNKSTNKS2PARP1ALOX5POLH
SCHEMBL491032 0.88 ALOX5 (0.78) TNKSTNKS2PARP1ALOX5POLH
SCHEMBL31167385 0.87 CYP3A4 (1.00) TNKSTNKS2PARP1ALOX5POLH
SCHEMBL157723 0.87 CYP3A4 (1.00) TNKSTNKS2PARP1ALOX5POLH
SCHEMBL158519 0.86 PTPRS (1.00) TNKSTNKS2PARP1ALOX5POLH
SCHEMBL2218499 0.86 POLH (0.75) TNKSTNKS2PARP1ALOX5POLH
SCHEMBL12757263 0.85 CSNK2A2 (0.74) TNKSTNKS2PARP1ALOX5POLH
SCHEMBL29929667 0.84 CSNK2A2 (0.81) TNKSTNKS2PARP1ALOX5POLH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12163004-B2 Polymer composites WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) 2024-12-10 US claimed
US-20240122894-A1 METHODS TO SYNTHESIZE FLAVONOID DIMERS AND OLIGOMERS AND THE USE THEREOF NATIONAL UNIVERSITY OF SINGAPORE (SG) 2024-04-18 US claimed
CN-114699402-B Use of flavonoids for preparing beta-lactamase inhibitor 陕西省微生物研究所 2024-02-06 CN claimed
EP-4259614-A1 METHODS TO SYNTHESIZE FLAVONOID DIMERS AND OLIGOMERS AND THE USE THEREOF National University of Singapore (SG) 2023-10-18 EP claimed
CN-116829544-A Synthesis method of flavonoid dimers and oligomers and application thereof 新加坡国立大学 2023-09-29 CN claimed
US-20230119060-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING, AS ACTIVE INGREDIENT, COMPLEX OF BIGUANIDE-BASED COMPOUND AND FLAVONE, HYDROXYFLAVONE, FLAVANONE, FLAVONE DERIVATIVE, HYDROXYFLAVONE DERIVATIVE, OR FLAVANONE DERIVATIVE MEDIENCE CO., LTD. (KR) 2023-04-20 US claimed
US-20220249431-A1 ANTIMYCOTIC Karl-Franzens-Universität Graz (AT) 2022-08-11 US claimed
CN-114699402-A Application of flavonoid compound in preparation of beta-lactamase inhibitor 陕西省微生物研究所 2022-07-05 CN claimed
WO-2022124994-A1 METHODS TO SYNTHESIZE FLAVONOID DIMERS AND OLIGOMERS AND THE USE THEREOF NATIONAL UNIVERSITY OF SINGAPORE (SG) 2022-06-16 WO claimed
CN-113174376-A Application of polyphenol oxidase and method for synthesizing flavone 四川大学 2021-07-27 CN claimed
US-20120009288-A1 USE OF ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE NATIONAL TAIWAN UNIVERSITY (TW) 2012-01-12 US claimed
US-7897637-B2 Methods of using flavonoids to enhance memory THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2011-03-01 US claimed
US-20100310688-A1 ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE NATIONAL TAIWAN UNIVERSITY (TW) 2010-12-09 US claimed
US-20080021096-A1 METHODS OF USING FLAVONOIDS TO ENHANCE MEMORY THE SALK INSTITUTE FOR BIOLOGICAL STUDIES 2008-01-24 US claimed
WO-2008011538-A2 METHODS OF USING FLAVONOIDS TO ENHANCE MEMORY THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2008-01-24 WO claimed
WO-2006001665-A1 COMPOSITION FOR PREVENTING OR TREATING ACUTE OR CHRONIC DEGENERATIVE BRAIN DISEASES INCLUDING FLAVONOID DERIVATIVES SEOUL NATIONAL UNIVERSITY INDUSTRY FOUNDATION (KR) 2006-01-05 WO claimed
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US claimed
JP-2003504327-A 2003-02-04 JP claimed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 EP claimed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021096-A1 METHODS OF USING FLAVONOIDS TO ENHANCE MEMORY FOS, CREBBP, CREB1 TNKS 4306/4885TNKS2 3851/4885PARP1 3164/4885
US-20240122894-A1 METHODS TO SYNTHESIZE FLAVONOID DIMERS AND OLIGOMERS AND THE USE THEREOF ERG28, MGAM, CTRB2 TNKS 3615/4885TNKS2 2755/4885PARP1 3677/4885
US-20120009288-A1 USE OF ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE XDH, AOX1, ACACA TNKS 2970/4885TNKS2 3115/4885PARP1 3425/4885
US-20220249431-A1 ANTIMYCOTIC ETF1, FOXM1, RIF1 TNKS 4403/4885TNKS2 4431/4885PARP1 3190/4885
US-20100310688-A1 ACACIA EXTRACTS AND THEIR COMPOUNDS ON INHIBITION OF XANTHINE OXIDASE XDH, ACACA, ACAT1 TNKS 2954/4885TNKS2 3202/4885PARP1 3452/4885
US-20230119060-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING, AS ACTIVE INGREDIENT, COMPLEX OF BIGUANIDE-BASED COMPOUND AND FLAVONE, HYDROXYFLAVONE, FLAVANONE, FLAVONE DERIVATIVE, HYDROXYFLAVONE DERIVATIVE, OR FLAVANONE DERIVATIVE SLC5A2, SLC5A1, SLC5A6 TNKS 4575/4885TNKS2 4500/4885PARP1 4024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.